about
Recombinant growth hormone for idiopathic short stature in children and adolescentsShortened peginterferon and ribavirin treatment for chronic hepatitis C.Adefovir dipivoxil and pegylated interferon alpha for the treatment of chronic hepatitis B: an updated systematic review and economic evaluation.The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation.Cost-effectiveness analysis of the introduction of the pneumococcal conjugate vaccine (PCV-13) in the Egyptian national immunization program, 2013.Clinical effectiveness and cost-effectiveness of depth of anaesthesia monitoring (E-Entropy, Bispectral Index and Narcotrend): a systematic review and economic evaluation.The clinical effectiveness and cost-effectiveness of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C in children and young people: a systematic review and economic evaluation.Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group's experience.Use of cardiac markers to assess the toxic effects of anthracyclines given to children with cancer: a systematic review.Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation.Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran.Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe.
P50
Q24244205-269CD236-0A61-46AC-A55C-217778015C1BQ31096653-3A139896-0C1D-4787-B1C9-DA57F4A1AA3EQ33483139-AE417488-61AF-4226-A6DA-B94DDDA5F5BEQ33499561-4DE9C4DC-CF75-40A7-960E-432027830643Q33865320-8C907BB9-B246-4209-949E-D4E3A5817BA4Q34473940-F600889A-34F6-4612-9BF7-6F0F66E75940Q34959017-5979AA84-9128-4477-812E-459569505C2AQ35371904-D479A789-80C4-48D9-92AD-78C9F636684EQ36219300-0271D6CF-6E8C-4F2E-8979-CA05850EEBA7Q36906051-4D228DCE-61AE-44F0-AF64-448F24CA7D3AQ37789794-42C49B90-9351-4044-B2D3-3F1E82CEC9D0Q38445972-F0CB56EE-1915-454E-A708-5BA095C7938AQ38445987-6BA5CD00-72A5-4F03-B68B-2CD61809552A
P50
description
researcher ORCID ID = 0000-0001-9737-9683
@en
name
L Baxter
@ast
L Baxter
@en
L Baxter
@nl
type
label
L Baxter
@ast
L Baxter
@en
L Baxter
@nl
prefLabel
L Baxter
@ast
L Baxter
@en
L Baxter
@nl
P31
P496
0000-0001-9737-9683